How Phases is building AI agents for clinical trial operations

Read through our secure, compliant approach to AI in clinical operations.

16x faster monitoring oversight for a Phase 1 oncology sponsor

An AI monitoring visit report review of 130+ monitoring reports surfaced 21 protocol deviations the sponsor had missed, 13 of which were never entered in the PD log.

July 21, 20266 min read
Building secure agents in clinical trials
Read more
July 14, 20267 min read
You can't trust ChatGPT or Claude to run your clinical trials
Read more
July 9, 20265 min read
21 CFR Part 11 wasn't written for AI agents
Read more
June 30, 20267 min read
Jevons paradox: Doing more with less in clinical trials
Read more
June 21, 20266 min read
The copilot ceiling in clinical trials
Read more
June 15, 202610 min read
The thing no one wants to admit about AI drug discovery
Read more

How Phases is building AI agents for clinical trial operations

16x faster monitoring oversight for a Phase 1 oncology sponsor

Latest articles

Building secure agents in clinical trials

You can't trust ChatGPT or Claude to run your clinical trials

21 CFR Part 11 wasn't written for AI agents

Jevons paradox: Doing more with less in clinical trials

The copilot ceiling in clinical trials

The thing no one wants to admit about AI drug discovery